Contact
searchSearch
HMP Global
Quiz

Trivia: Internalized Skin Bias in HS

Jessica Garlewicz
05/17/2022

Related Content

Videos
Hidradenitis Suppurativa: Early Recognition, IL-17 Targeted Therapies, and Multidisciplinary Care
04/01/2026
Riya Gandhi, MA
Dr Jack O’Brien discusses how dermatologists can reduce diagnostic delays in hidradenitis suppurativa by recognizing early clinical signs such as recurrent abscesses in intertriginous areas and associated acne.
Dr Jack O’Brien discusses how dermatologists can reduce diagnostic delays in hidradenitis suppurativa by recognizing early clinical signs such as recurrent abscesses in intertriginous areas and associated acne.
Dr Jack O’Brien discusses how...
04/01/2026
The Dermatologist
News
Emerging JAK1 and C5a Inhibitors Show Promise in Hidradenitis Suppurativa Network Meta-Analysis
03/31/2026
Riya Gandhi, MA
Comparative data highlight improved efficacy and tolerability signals with investigational therapies vs current standards.
Comparative data highlight improved efficacy and tolerability signals with investigational therapies vs current standards.
Comparative data highlight...
03/31/2026
The Dermatologist
News
Povorcitinib Demonstrates Meaningful Clinical Response in Anti-TNF–Experienced Hidradenitis Suppurativa Patients at 24 Weeks
03/31/2026
Riya Gandhi, MA
Phase 3 interim data show improved HiSCR responses and rapid pain reduction in a difficult-to-treat population.
Phase 3 interim data show improved HiSCR responses and rapid pain reduction in a difficult-to-treat population.
Phase 3 interim data show...
03/31/2026
The Dermatologist
FDA Alerts
FDA Approves Cosentyx for the Treatment of Pediatric Patients Aged 12 Years and Older With Moderate-To-Severe Hidradenitis Suppurativa
03/17/2026
Jessica Garlewicz
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug...
03/17/2026
The Dermatologist

Popular Articles

Aging and Geriatric Evaluation in Dermatology
Podcasts
The ElderDerm: Episode 2, Aging and Geriatric Evaluation in Dermatology
04/22/2024
Adam Friedman, MD; Jaya Manjunath
In this episode of the ElderDerm Podcast, co-hosts Dr Adam Friedman and Jaya Manjunath discuss the Aging and Geriatric Evaluation in Dermatology (AGED) workgroup.
In this episode of the ElderDerm Podcast, co-hosts Dr Adam Friedman and Jaya Manjunath discuss the Aging and Geriatric Evaluation in Dermatology (AGED) workgroup.
In this episode of the ElderDerm...
04/22/2024
The Dermatologist
Susan Taylor, MD, FAAD
Conference Coverage
Updates in Pigmentary Disorders
05/11/2024
Jessica Garlewicz
On the final day of Spring Dermatology Week 2024, Susan Taylor, MD, FAAD, discussed management approaches to melasma and pigmentary disorders during her session, “Management Approach to Melasma/Pigmentary Disorders.”
On the final day of Spring Dermatology Week 2024, Susan Taylor, MD, FAAD, discussed management approaches to melasma and pigmentary disorders during her session, “Management Approach to Melasma/Pigmentary Disorders.”
On the final day of Spring...
05/11/2024
The Dermatologist
AD
News
Ruxolitinib Cream for Patients With Facial and/or Neck Atopic Dermatitis
06/19/2024
Jessica Garlewicz
In a presentation showcased at the Revolutionizing Atopic Dermatitis (RAD) June 2024 meeting, a study evaluated the efficacy and safety of 1.5% ruxolitinib cream in treating AD in face/neck.
In a presentation showcased at the Revolutionizing Atopic Dermatitis (RAD) June 2024 meeting, a study evaluated the efficacy and safety of 1.5% ruxolitinib cream in treating AD in face/neck.
In a presentation showcased at...
06/19/2024
The Dermatologist
Surgical Pearls
Dermatologic Surgery Pearls for Non-Mohs Surgeons
08/07/2024
Riya Gandhi, MA
Consider words of wisdom from your colleagues and share what you have learned with others to help optimize patient care.
Consider words of wisdom from your colleagues and share what you have learned with others to help optimize patient care.
Consider words of wisdom from...
08/07/2024
The Dermatologist
psoriasis
News
Managing Nail Psoriasis and Nail Lichen Planus
09/25/2024
Jessica Garlewicz
A literature review was conducted to explore recent studies focusing on diagnostic approaches and treatment options for nail psoriasis and nail lichen planus.
A literature review was conducted to explore recent studies focusing on diagnostic approaches and treatment options for nail psoriasis and nail lichen planus.
A literature review was...
09/25/2024
The Dermatologist
cover March 2026

Current Issue

March 2026
Volume 34
Issue 2
Current Issue
Issue Archive

Latest Quizzes and Trivia

Quiz
Type 2 Inflammation and Early Systemic Therapy in Pediatric Atopic Dermatitis
04/05/2026
Riya Gandhi, MA
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical...
04/05/2026
The Dermatologist
Quiz
Disease Heterogeneity in PN
03/15/2026
Riya Gandhi, MA
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of...
03/15/2026
The Dermatologist
Quiz
Rethinking Severity and JAK Inhibitor Strategy in Alopecia Areata
03/12/2026
Riya Gandhi, MA
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine...
03/12/2026
The Dermatologist
Quiz
Cytokine Hierarchy and Sustained Pruritus in PN
03/10/2026
Riya Gandhi, MA
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and...
03/10/2026
The Dermatologist
Quiz
Type 2 Inflammation as a Pathogenic Driver in Prurigo Nodularis
03/05/2026
Riya Gandhi, MA
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how...
03/05/2026
The Dermatologist
psoriasis
Quiz
Distinguishing Feature of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing...
03/02/2026
The Dermatologist
psoriasis
Quiz
Quiz: Misdiagnosis of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized...
03/02/2026
The Dermatologist
Quiz
Allergic Disease Progression: Genetics and Environment
02/26/2026
Riya Gandhi, MA
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between...
02/26/2026
The Dermatologist
Quiz
Early Intervention Strategies in Pediatric Atopic Dermatitis
02/26/2026
Riya Gandhi, MA
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of...
02/26/2026
The Dermatologist
Quiz
Air Pollution and Atopic Disease: Evaluating Epidemiologic Evidence
02/26/2026
Riya Gandhi, MA
Test your knowledge of the epidemiologic data examining environmental exposures and their association with atopic disease development. This quiz explores key population-level observations shaping modern allergy research.
Test your knowledge of the epidemiologic data examining environmental exposures and their association with atopic disease development. This quiz explores key population-level observations shaping modern allergy research.
Test your knowledge of the...
02/26/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use